Child

Prevalence

0.1 / 100K

61 drugs in development·31 companies·5 clinical trials

Drug Pipeline by Phase

Approved(25)

Drug	Company
arcalyst	X4 Pharmaceuticals, Inc (XFOR)
candesartan cilexetil	Aptinyx Inc. (APTX)
colchicine	Mylan II B.V. (MYL)
dextroamp saccharate	ANI PHARMACEUTICALS INC (ANIP)
dna appliance	Vivos Therapeutics Inc. (VVOS)
dsuvia	Verrica Pharmaceuticals Inc. (VRCA)
FYCOMPA®	CATALYST PHARMACEUTICALS, INC. (CPRX)
imipramine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
ipratropium	Amneal Pharmaceuticals, Inc. (AMRX)
losartan	Mylan II B.V. (MYL)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
mavyret	AbbVie Inc. (ABBV)
oxcarbazepine	ANI PHARMACEUTICALS INC (ANIP)
Oxtellar XR	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Poly-Vi-Flor	AYTU BIOPHARMA, INC (AYTU)
rivfloza	Novo Nordisk A/S (NVO)
sevelamer carbonate	Impax Laboratories, LLC (IPXL)
sevelamer carbonate	DR REDDYS LABORATORIES LTD (RDY)
somatrogon	OPKO HEALTH, INC. (OPK)
supprelin la	Endo LP (NDOI)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
Tri-Vi-Flor	AYTU BIOPHARMA, INC (AYTU)
valsartan	Mylan II B.V. (MYL)
verkazia	HARROW, INC. (IMMY)
zafirlukast	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(8)

Drug	Company
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Haematopoietic growth factor	Structure Therapeutics Inc. (GPCR)
Lomustine	Filana Therapeutics Inc. (FLNA)
norditropin	Novo Nordisk A/S (NVO)
norditropin flexpro	Novo Nordisk A/S (NVO)
remestemcel-l	Mesoblast Limited (MESO)
Sodium Thiosulfate	Filana Therapeutics Inc. (FLNA)
somapacitan	Novo Nordisk A/S (NVO)

Phase 2(10)

Drug	Company
Fludarabine	Structure Therapeutics Inc. (GPCR)
Fludarabine phosphate	Structure Therapeutics Inc. (GPCR)
Haploidentical donor bone marrow transplant	Structure Therapeutics Inc. (GPCR)
Hematopoietic stem cell transplant	Structure Therapeutics Inc. (GPCR)
Melphalan	Structure Therapeutics Inc. (GPCR)
Plerixafor	Structure Therapeutics Inc. (GPCR)
R21/Matrix-M1	Valneva SE (VALN)
Rabbit Anti thymocyte globulin	Structure Therapeutics Inc. (GPCR)
SG301 Subcutaneous injection	FATE THERAPEUTICS INC (FATE)
Thiotepa	Structure Therapeutics Inc. (GPCR)

Phase 1(9)

Drug	Company
Busulfan	Structure Therapeutics Inc. (GPCR)
group a standard-of-care backbone therapy	National Research Corporation Common Stock (Delaware) (NRC)
IL-2	Structure Therapeutics Inc. (GPCR)
IL-2	ENANTA PHARMACEUTICALS INC (ENTA)
memory-like natural killer cells	Structure Therapeutics Inc. (GPCR)
mRNA plus Lysate-loaded Dendritic Cell Vaccine	Structure Therapeutics Inc. (GPCR)
PEGYLATED-INTERFERON ALPHA-2A	Structure Therapeutics Inc. (GPCR)
Peripheral Blood Stem Cell Infusion	Structure Therapeutics Inc. (GPCR)
Thiotepa	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(1)

Drug	Company
vby329	Invivyd, Inc. (IVVD)

Unknown(2)

Drug	Company
diphenhydramine	Mesoblast Limited (MESO)
The Satchel™	American Cannabis Company, Inc. (AMMJ)

Phase 4(6)

Drug	Company
avapritinib	Blueprint Medicines Corp (BPMC)
Granulocyte Colony-Stimulating Factor	Structure Therapeutics Inc. (GPCR)
omalizumab	GH Research PLC (GHRS)
Recombinant Granulocyte Colony-Stimulating Factor	Structure Therapeutics Inc. (GPCR)
Vincristine	Filana Therapeutics Inc. (FLNA)
Vincristine Sulfate Liposome	Filana Therapeutics Inc. (FLNA)

BioSniper tracks 61 drugs in development for Child across 31 companies.

There are 5 clinical trials targeting Child tracked by BioSniper.

The estimated prevalence of Child is approximately 0.1 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.